Annual Current Liabilities
$24.37 M
+$7.83 M+47.30%
31 December 2023
Summary:
Keros Therapeutics annual total current liabilities is currently $24.37 million, with the most recent change of +$7.83 million (+47.30%) on 31 December 2023. During the last 3 years, it has risen by +$17.19 million (+239.27%). KROS annual current liabilities is now at all-time high.KROS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$29.01 M
+$7.76 M+36.54%
30 September 2024
Summary:
Keros Therapeutics quarterly total current liabilities is currently $29.01 million, with the most recent change of +$7.76 million (+36.54%) on 30 September 2024. Over the past year, it has increased by +$12.31 million (+73.68%). KROS quarterly current liabilities is now at all-time high.KROS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.3% | +73.7% |
| 3 y3 years | +239.3% | +163.3% |
| 5 y5 years | +112.5% | - |
KROS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +239.3% | at high | +163.3% |
| 5 y | 5 years | at high | +443.3% | at high | +546.6% |
| alltime | all time | at high | +443.3% | at high | +546.6% |
Keros Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.01 M(+36.5%) |
| June 2024 | - | $21.25 M(+13.5%) |
| Mar 2024 | - | $18.72 M(-23.2%) |
| Dec 2023 | $24.37 M(+47.3%) | $24.37 M(+45.9%) |
| Sept 2023 | - | $16.70 M(+3.8%) |
| June 2023 | - | $16.09 M(+4.1%) |
| Mar 2023 | - | $15.46 M(-6.6%) |
| Dec 2022 | $16.55 M | $16.55 M(+43.6%) |
| Sept 2022 | - | $11.53 M(-25.4%) |
| June 2022 | - | $15.45 M(+32.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.65 M(-1.7%) |
| Dec 2021 | $11.85 M(+64.9%) | $11.85 M(+7.5%) |
| Sept 2021 | - | $11.02 M(+46.3%) |
| June 2021 | - | $7.53 M(-15.9%) |
| Mar 2021 | - | $8.95 M(+24.6%) |
| Dec 2020 | $7.18 M(+60.1%) | $7.18 M(+5.3%) |
| Sept 2020 | - | $6.83 M(-17.7%) |
| June 2020 | - | $8.29 M(-6.1%) |
| Mar 2020 | - | $8.84 M(+97.0%) |
| Dec 2019 | $4.49 M(-60.9%) | $4.49 M |
| Dec 2018 | $11.47 M | - |
FAQ
- What is Keros Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual current liabilities year-on-year change?
- What is Keros Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly current liabilities year-on-year change?
What is Keros Therapeutics annual total current liabilities?
The current annual current liabilities of KROS is $24.37 M
What is the all time high annual current liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total current liabilities is $24.37 M
What is Keros Therapeutics annual current liabilities year-on-year change?
Over the past year, KROS annual total current liabilities has changed by +$7.83 M (+47.30%)
What is Keros Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of KROS is $29.01 M
What is the all time high quarterly current liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total current liabilities is $29.01 M
What is Keros Therapeutics quarterly current liabilities year-on-year change?
Over the past year, KROS quarterly total current liabilities has changed by +$12.31 M (+73.68%)